Macquarie University Hospital Clinical Trials Unit

Sydney, New South Wales 2109

0 studies enrolling now · 1 studies all time

What they study most

HER2 Positive Solid Tumors

Studies at this site

• A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors — Status unconfirmed